PMID- 14629626 OWN - NLM STAT- MEDLINE DCOM- 20031210 LR - 20190818 IS - 0300-9475 (Print) IS - 0300-9475 (Linking) VI - 58 IP - 5 DP - 2003 Nov TI - Uptake of Apoptotic K562 Leukaemia Cells by Immature Dendritic Cells is Greatly Facilitated by Serum. PG - 541-9 AB - Dendritic cells (DCs) are potent antigen-presenting cells and play an important role in T-cell-mediated immunity. DCs have been shown to induce strong antitumour immune responses both in vitro and in vivo. One way of providing the DCs with all relevant tumour antigens would be to incubate the DCs with material from dead tumour cells. We have examined the uptake of apoptotic and necrotic K562 leukaemia cells by DCs under different culture conditions. Results from coincubation experiments strongly suggested that uptake of apoptotic K562 cells was dependent upon the addition of autologous serum (AS). Under these conditions, 47-79% of all DCs were shown to ingest apoptotic material. AS also seemed to be important for the expression of functionally important markers, most notably HLA class I, CD86, CCR7 and CD83. The vast majority of DCs were shown to ingest necrotic material from K562 cells, with no additional effect of AS. The results suggest that incubation of DCs with apoptotic material for cell therapeutic purposes may best be performed in the presence of AS. FAU - Dalgaard, J AU - Dalgaard J AD - Institute of Immunology, Rikshospitalet University Hospital, Oslo, Norway. jakob.dalgaard@labmed.uio.no FAU - Beckstrom, K J AU - Beckstrom KJ FAU - Brinchmann, J E AU - Brinchmann JE LA - eng PT - Journal Article PL - England TA - Scand J Immunol JT - Scandinavian journal of immunology JID - 0323767 SB - IM MH - *Apoptosis MH - Dendritic Cells/*immunology MH - Endocytosis MH - Humans MH - Immunophenotyping MH - K562 Cells/*pathology MH - Necrosis MH - Serum/*physiology EDAT- 2003/11/25 05:00 MHDA- 2003/12/12 05:00 CRDT- 2003/11/25 05:00 PHST- 2003/11/25 05:00 [pubmed] PHST- 2003/12/12 05:00 [medline] PHST- 2003/11/25 05:00 [entrez] AID - 1332 [pii] AID - 10.1046/j.1365-3083.2003.01332.x [doi] PST - ppublish SO - Scand J Immunol. 2003 Nov;58(5):541-9. doi: 10.1046/j.1365-3083.2003.01332.x.